PEN Penumbra, Inc. Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 30, 2026
$317,55
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$221,2652 haftanın en düşüğü
$362,4152 haftanın en yükseği
Piyasa Değeri
$12.46B
P/E (TTM)
78.0
Hisse Başına Kâr (TTM)
$4.07
Gelir (TTM)
$1.50B
rozetleriniz
52 Haftlık Aralık
$221–$362
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$362
P/E
78.0
ROE
11.4%
Net Kâr Marjı
10.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
PEN Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$317.55
Piyasa Değeri
$12.46B
P/E (TTM)
78.0
Hisse Başına Kâr (TTM)
$4.07
Gelir (TTM)
$1.50B
ROE (TTM)
11.4%
52 Haftlık Aralık
$221–$362
PEN Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Penumbra, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.
History
Penumbra was founded in 2004 and manufactures several medical devices but specializes in the neuro/vascular market and creates devices that help treat aneurysms and ischemic stroke.
In 2014, Penumbra launched its Apollo system, a device that “enables minimally invasive removal of deeply seated tissue and fluids in the brain,” allowing for otherwise inoperable blood clots to be removed.
In 2015 the company issued an initial public offering on the New York Stock Exchange. In 2018 the company acquired 40% of the outstanding shares of virtual reality joint venture MVI Health. In 2017 the company acquired the Italian distributor Crossmed.
Criticism
Criticism of Penumbra has followed various aspects of its products and business practices. In 2016 a lawsuit claimed the Penumbra Coil 400 caused brain damage after surgery. The company's specialized catheter has been linked to the deaths of stroke patients, and it was a target of stock short sellers in 2020. According to the Foundation for Financial Journalism, this is a significant dilemma.
A request has been sent to The SEC and U.S. Food and Drug Administration to launch an investigation. A scientist who has published research articles showing the reliability of Penumbra's medical products is (allegedly) an internet fabrication.
Recalls
In 2011 the company recalled its Penumbra Coil 400. In 2017 the company recalled a 3D revascularization device. In 2020 the company recalled one of its catheter used during heart surgery due to increased risk of mortality and serious injury.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
sektörHealth Care
endüstriHealth Care
çalışanlar4.700
ülkeUS
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$1.40B2018-12-31 → 2025-12-31
Hisse Başına Kâr$4.522018-12-31 → 2025-12-31
Serbest Nakit Akışı$175M2018-12-31 → 2025-12-31
Net kar marjı10.7%2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | PEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 78.05Y ort. ≈-312.0 | ≈-312.0 | 23.8 | Aşırı değerli | |
| P/S (F/S) | 8.95Y ort. ≈10.0 | ≈10.0 | 3.9 | Aşırı değerli | |
| P/B (F/D) | 8.75Y ort. ≈8.9 | ≈8.9 | 4.6 | Aşırı değerli | |
| Price / FCF (Fiyat / Serbest Nakit Akışı) | 71.25Y ort. ≈-157.5 | ≈-157.5 | · | · | |
| Price / Cash Flow (Fiyat / Nakit Akışı) | 52.25Y ort. ≈237.9 | ≈237.9 | 17.3 | Aşırı değerli | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 9.95Y ort. ≈11.2 | ≈11.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | PEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Brüt Kar Marjı (TTM) | 67.8%5Y ort. ≈64.3% | ≈64.3% | 62.3% | En üst düzey | |
| Faaliyet Kâr Marjı (TTM) | 12.4%5Y ort. ≈4.2% | ≈4.2% | 14.5% | Zayıf | |
| FAVÖK Marjı (TTM) | 13.6%5Y ort. ≈6.4% | ≈6.4% | 14.5% | Zayıf | |
| Vergi Öncesi Kar Marjı (TTM) | 13.5%5Y ort. ≈4.6% | ≈4.6% | 12.6% | Zayıf | |
| Net Kâr Marjı (TTM) | 10.7%5Y ort. ≈4.6% | ≈4.6% | 9.8% | Zayıf | |
| ROA (TTM) | 8.8%5Y ort. ≈3.6% | ≈3.6% | 7.8% | En üst düzey | |
| ROE (TTM) | 11.4%5Y ort. ≈4.5% | ≈4.5% | 13.1% | Aynı seviyede | |
| ROIC | 11.5%5Y ort. ≈3.8% | ≈3.8% | 9.9% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | PEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 5.75Y ort. ≈5.9 | ≈5.9 | 2.2 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 2.15Y ort. ≈2.2 | ≈2.2 | 1.1 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | PEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 17.5%5Y ort. ≈20.4% | ≈20.4% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 18.3%5Y ort. ≈19.6% | ≈19.6% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 20.2% | · | · | · | |
| EPS YoY (EPS YB) | 1155.6% | · | · | · | |
| Net Income YoY (Net Gelir Yıllık Bazda) | 1168.1% | · | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 37.0% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 38.4% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | PEN | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.85Y ort. ≈0.7 | ≈0.7 | 0.6 | En üst düzey | |
| Inventory Turnover (Stok Devir Hızı) | 1.15Y ort. ≈1.1 | ≈1.1 | 1.8 | Zayıf | |
| Receivables Turnover (Alacak Devir Hızı) | 7.85Y ort. ≈6.0 | ≈6.0 | 5.8 | En üst düzey | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$298.7K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-2.4%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 27, 2026 | $0.88 | $1.20 | -26.6% |
| 31 Mart 2026 | $0.82 | $1.09 | -24.5% | |
| 31 Aralık 2025 | $1.18 | $1.12 | 5.0% | |
| 30 Eylül 2025 | $0.97 | $0.93 | 4.2% | |
| 30 Haziran 2025 | $0.86 | $0.83 | 3.6% | |
| 31 Mart 2025 | $0.83 | $0.67 | 23.9% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Cost of Revenue | $461M | $440M | $376M | $312M | $272M | $222M | $175M | · | $117M | $92M | |
| Gross Profit | $942M | $755M | $683M | $535M | $475M | $338M | $372M | · | $217M | $171M | |
| R&D Expense | · | · | · | · | · | · | · | · | $32M | $24M | |
| SG&A Expense | $663M | $574M | $506M | $450M | $378M | $287M | $273M | · | $184M | $148M | |
| Operating Expenses | $753M | $746M | $609M | $529M | $483M | $377M | $324M | · | $216M | $172M | |
| Operating Income | $189M | $9M | $74M | $6M | $-8M | $-39M | $48M | · | $1M | $-1M | |
| Interest Expense | · | · | $2M | $2M | $2M | · | · | · | · | · | |
| Interest Income | $16M | $14M | $7M | $2M | $3M | · | · | · | · | · | |
| Other Non-op | $893.0K | $-682.0K | $1M | $-2M | $-4M | $-343.0K | $-227.0K | · | $-1M | $-2M | |
| Pretax Income | $205M | $21M | $80M | $4M | $-11M | $-38M | $50M | · | $2M | $-869.0K | |
| Income Tax | $27M | $7M | $-11M | $6M | $-13M | $-19M | $3M | · | $-4M | $-16M | |
| Net Income | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| EPS (Basic) | $4.57 | $0.36 | $2.37 | $-0.05 | $0.14 | $-0.44 | $1.39 | · | $0.14 | $0.49 | |
| EPS (Diluted) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 | |
| Shares (Basic) | 38,918,493 | 38,633,744 | 38,401,171 | 37,841,874 | 36,764,290 | 35,766,892 | 34,750,706 | · | 32,978,065 | 30,464,583 | |
| Shares (Diluted) | 39,291,828 | 39,268,037 | 39,216,564 | 37,841,874 | 37,881,180 | 35,766,892 | 36,265,999 | · | 35,319,103 | 33,478,078 | |
| EBITDA | $207M | $33M | $101M | $30M | $9M | $-26M | $56M | · | $5M | $950.0K |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $187M | $324M | $167M | $70M | $59M | $70M | $73M | · | $51M | $13M | |
| Short-term Investments | · | · | · | · | · | $195M | $117M | · | $164M | $116M | |
| Receivables | $190M | $168M | $202M | $203M | $134M | $115M | $106M | · | $58M | $43M | |
| Inventory | $432M | $407M | $388M | $334M | $264M | $220M | $153M | · | $95M | $73M | |
| Prepaid Expense | $50M | $37M | $36M | $30M | $29M | $19M | $15M | $12M | $15M | $19M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $7M | $9M | |
| Current Assets | $1.22B | $951M | $915M | $756M | $681M | $618M | $463M | $410M | $382M | $264M | |
| PP&E (Net) | $117M | $63M | $73M | $65M | $59M | $48M | $52M | · | $31M | $21M | |
| PP&E (Gross) | $194M | $137M | $132M | $113M | $97M | $78M | $73M | · | $41M | $28M | |
| Accum. Depreciation | $77M | $74M | $60M | $48M | $38M | $30M | $21M | · | $11M | $7M | |
| Goodwill | $167M | $166M | $166M | $166M | $166M | $8M | $8M | · | $8M | $0 | |
| Intangibles | $6M | $7M | $71M | $81M | $91M | $11M | $25M | · | $24M | $0 | |
| Other Non-current Assets | $41M | $41M | $26M | $13M | $13M | $9M | $3M | · | $1M | $487.0K | |
| Total Assets | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Accounts Payable | $35M | $31M | $27M | $27M | $13M | $14M | $15M | · | $7M | $4M | |
| Accrued Liabilities | $132M | $112M | $111M | $106M | $100M | $86M | $68M | $58M | $45M | $32M | |
| Current Liabilities | $183M | $158M | $151M | $145M | $123M | $106M | $91M | $70M | $52M | $36M | |
| Capital Leases | $183M | $187M | $197M | $199M | $137M | $44M | $47M | $47M | · | · | |
| Deferred Tax | · | · | · | · | · | · | $4M | · | $3M | $824.0K | |
| Other Non-current Liabilities | $12M | $15M | $5M | $3M | $4M | $8M | $15M | · | $18M | $824.0K | |
| Total Liabilities | $399M | $382M | $377M | $372M | $290M | $185M | $180M | $135M | $76M | $42M | |
| Common Stock | $39.0K | $38.0K | $39.0K | $38.0K | $37.0K | $36.0K | $35.0K | · | $33.0K | $31.0K | |
| Paid-in Capital | $1.19B | $1.10B | $1.05B | $963M | $911M | $598M | $431M | · | $397M | $274M | |
| Retained Earnings | $238M | $60M | $135M | $44M | $46M | $41M | $58M | · | $2M | $-3M | |
| AOCI | $4M | $-6M | $-3M | $-8M | $-3M | $3M | $-2M | · | $2M | $-5M | |
| Stockholders' Equity | $1.43B | $1.15B | $1.18B | $999M | $954M | $638M | $486M | · | $400M | $267M | |
| Liabilities + Equity | $1.83B | $1.53B | $1.56B | $1.37B | $1.24B | $823M | $666M | $558M | $477M | $308M | |
| Shares Outstanding | 39,229,670 | 38,490,836 | 38,681,549 | 38,107,977 | 37,578,483 | 36,414,732 | 35,001,581 | · | 33,685,146 | 31,108,828 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $17M | $24M | $27M | $24M | $16M | $13M | $8M | · | $4M | $2M | |
| Stock-based Comp | $59M | $46M | $51M | $37M | $66M | $26M | $21M | · | $18M | $15M | |
| Deferred Tax | $21M | $-16M | $-25M | $1M | $-15M | $-20M | $1M | · | $-5M | $-13M | |
| Amort. of Intangibles | $712.0K | $5M | $10M | $9M | $3M | $1M | $1M | · | $418.0K | $0 | |
| Restructuring | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-37M | $101M | $-46M | $-116M | $-63M | $-36M | $-53M | · | $-9M | $-32M | |
| Operating Cash Flow | $239M | $168M | $97M | $-56M | $10M | $-33M | $27M | · | $13M | $-13M | |
| CapEx | $64M | $21M | $15M | $19M | $21M | $25M | $22M | · | $13M | $14M | |
| Investing Cash Flow | $-405M | $78M | $-16M | $55M | $-22M | $-104M | $-13M | · | $-78M | $687.0K | |
| Stock Issued | · | · | · | $0 | $0 | $135M | $0 | · | $106M | $0 | |
| Stock Repurchased | $0 | $100M | $0 | $0 | · | · | · | · | · | · | |
| Net Stock Activity | $0 | $-100M | · | $0 | $0 | $135M | $0 | · | $106M | · | |
| Financing Cash Flow | $27M | $-87M | $16M | $12M | $836.0K | $135M | $-9M | · | $104M | $7M | |
| Net Change in Cash | $-138M | $157M | $98M | $10M | $-10M | $-3M | $5M | · | $37M | $-6M | |
| Taxes Paid | $15M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $175M | $147M | $82M | $-75M | $-12M | $-58M | $5M | · | $159.0K | $-26M | |
| Levered FCF | · | · | $80M | · | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% | 60.3% | 68.0% | · | 65.1% | 64.9% | |
| Operating Margin | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% | -7.0% | 8.7% | · | 0.35% | -0.51% | |
| Net Margin | 12.7% | 1.2% | 8.6% | -0.24% | 0.71% | -2.8% | 8.8% | · | 1.4% | 5.6% | |
| Pretax Margin | 14.6% | 1.8% | 7.5% | 0.46% | -1.4% | -6.8% | 9.2% | · | 0.74% | -0.33% | |
| EBITDA Margin | 14.7% | 2.8% | 9.5% | 3.6% | 1.2% | -4.7% | 10.2% | · | 1.5% | 0.36% | |
| ROA | 10.6% | 0.91% | 6.2% | -0.15% | 0.49% | -2.1% | 7.9% | · | 1.2% | 4.8% | |
| ROE | 13.1% | 1.2% | 8.0% | -0.20% | 0.64% | -2.8% | 10.7% | · | 1.4% | 5.6% | |
| ROIC | 11.5% | 0.54% | 7.1% | -0.31% | 0.20% | -3.1% | 9.2% | · | 0.72% | 8.6% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 | 5.8 | 5.1 | · | 7.4 | 7.4 | |
| Quick Ratio | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 | 3.6 | 3.2 | · | 5.3 | 4.8 | |
| Interest Coverage | · | · | 42.3 | · | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.8 | 0.7 | 0.6 | 0.7 | 0.8 | 0.9 | · | 0.9 | 0.9 | |
| Inventory Turnover | 1.1 | 1.1 | 1.0 | 1.0 | 1.1 | 1.2 | 1.3 | · | 1.4 | 1.4 | |
| Receivables Turnover | 7.8 | 6.5 | 5.2 | 5.0 | 5.5 | 5.1 | 5.8 | · | 6.6 | 7.2 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $36.39 | $29.90 | $30.48 | $26.21 | $25.38 | $17.62 | $13.88 | · | $11.89 | $8.57 | |
| Revenue / Share | $35.72 | $30.42 | $26.99 | $22.39 | $19.74 | $15.67 | $15.09 | · | $9.45 | $7.87 | |
| Cash Flow / Share | $6.07 | $4.29 | $2.48 | $-1.47 | $0.25 | $-0.93 | $0.73 | · | $0.36 | $-0.38 | |
| Cash / Share | $4.76 | $8.43 | $4.33 | $1.83 | $1.58 | $1.91 | $2.08 | · | $1.50 | $0.43 | |
| EPS (TTM) | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 | $-0.44 | $1.34 | · | $0.13 | $0.44 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 17.5% | 12.9% | 24.9% | 13.3% | 33.4% | · | · | · | · | · | |
| Revenue CAGR 3Y | 18.3% | 16.9% | 23.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.2% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 1155.6% | -84.5% | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | 37.0% | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1168.1% | -84.6% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | 38.4% | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.40B | $1.19B | $1.06B | $847M | $748M | $560M | $547M | · | $334M | $263M | |
| Net Income TTM | $178M | $14M | $91M | $-2M | $5M | $-16M | $48M | · | $5M | $15M | |
| Market Cap | $12.20B | $9.14B | $9.73B | $8.48B | $10.80B | $6.37B | $5.75B | · | $3.17B | $1.98B | |
| P/E | 68.8 | 659.7 | 108.4 | -4449.2 | 2052.3 | -397.7 | 122.6 | · | 723.8 | 145.0 | |
| P/S | 8.7 | 7.7 | 9.2 | 10.0 | 14.4 | 11.4 | 10.5 | · | 9.5 | 7.5 | |
| P/B | 8.5 | 7.9 | 8.3 | 8.5 | 11.3 | 9.9 | 11.8 | · | 7.9 | 7.4 | |
| P / Tangible Book | 9.7 | 9.3 | 10.3 | 11.3 | 15.5 | 10.3 | · | · | · | · | |
| P / Cash Flow | 51.1 | 54.3 | 100.0 | -152.3 | 1136.3 | -191.7 | 215.7 | · | 249.8 | -155.0 | |
| P / FCF | 69.7 | 62.1 | 118.5 | -113.1 | -924.6 | -109.9 | 1265.6 | · | 19935.7 | -75.1 | |
| Earnings Yield | 1.5% | 0.15% | 0.92% | -0.02% | 0.05% | -0.25% | 0.82% | · | 0.14% | 0.69% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $390M | $375M | $385M | $355M | $339M | $324M | $316M | $301M | $299M | $279M | $285M | $271M | $261M | $241M | $221M | $214M | |
| Cost of Revenue | $125M | $121M | $123M | $114M | $115M | $108M | $105M | $101M | $137M | $98M | $98M | $93M | $95M | $90M | $83M | $78M | |
| Gross Profit | $265M | $253M | $262M | $240M | $224M | $216M | $211M | $200M | $163M | $181M | $187M | $178M | $167M | $151M | $138M | $135M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | $22M | $20M | · | $21M | |
| SG&A Expense | $199M | $193M | $181M | $169M | $160M | $153M | $148M | $140M | $142M | $144M | $130M | $126M | $127M | $123M | $116M | $109M | |
| Operating Expenses | $224M | $215M | $203M | $192M | $183M | $176M | $168M | $165M | $244M | $169M | $152M | $165M | $149M | $143M | $134M | $130M | |
| Operating Income | $41M | $38M | $59M | $49M | $41M | $40M | $43M | $35M | $-81M | $12M | $35M | $13M | $18M | $8M | $5M | $5M | |
| Interest Expense | · | · | · | · | · | · | · | · | $344.0K | $402.0K | · | · | $444.0K | $416.0K | · | · | |
| Interest Income | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | $2M | $1M | $970.0K | · | · | |
| Other Non-op | $-456.0K | $-1M | $171.0K | $-535.0K | $812.0K | $445.0K | $-1M | $1M | $-226.0K | $-366.0K | $559.0K | $-444.0K | $808.0K | $90.0K | $2M | $-2M | |
| Pretax Income | $46M | $42M | $64M | $52M | $45M | $44M | $44M | $40M | $-78M | $15M | $38M | $13M | $20M | $9M | $7M | $3M | |
| Income Tax | $11M | $9M | $16M | $6M | $0 | $5M | $11M | $10M | $-18M | $4M | $-16M | $4M | $576.0K | $90.0K | $3M | $5M | |
| Net Income | $35M | $33M | $47M | $46M | $45M | $39M | $34M | $30M | $-60M | $11M | $54M | $9M | $19M | $9M | $4M | $-2M | |
| EPS (Basic) | $0.88 | $0.83 | $1.21 | $1.17 | $1.17 | $1.02 | $0.87 | $0.76 | $-1.55 | $0.28 | $1.42 | $0.24 | $0.49 | $0.22 | $0.11 | $-0.06 | |
| EPS (Diluted) | $0.88 | $0.82 | $1.20 | $1.17 | $1.15 | $1.00 | $0.88 | $0.75 | $-1.55 | $0.28 | $1.39 | $0.23 | $0.48 | $0.22 | $0.11 | $-0.06 | |
| Shares (Basic) | 39,353,965 | 39,275,424 | · | 39,078,378 | 38,834,917 | 38,562,191 | · | 38,610,805 | 38,793,341 | 38,717,334 | 38,628,565 | 38,462,463 | 38,320,999 | 38,186,342 | 38,030,344 | 37,918,452 | |
| Shares (Diluted) | 39,572,059 | 39,543,780 | · | 39,302,239 | 39,245,953 | 39,163,428 | · | 39,178,227 | 38,793,341 | 39,387,359 | 39,291,044 | 39,219,966 | 39,201,155 | 39,075,388 | 38,896,940 | 37,918,452 | |
| EBITDA | $41M | $43M | · | $49M | $41M | $45M | · | $35M | $-81M | $20M | · | $13M | $18M | $15M | · | $5M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $241M | $187M | $321M | $422M | $376M | $324M | $280M | $288M | $223M | · | $101M | $114M | $95M | · | $55M | |
| Receivables | $190M | $183M | $190M | $183M | $176M | $168M | $168M | $176M | $201M | $192M | · | $207M | $209M | $207M | · | $189M | |
| Inventory | $443M | $439M | $432M | $432M | $428M | $416M | $407M | $393M | $374M | $398M | · | $374M | $359M | $344M | · | $320M | |
| Prepaid Expense | $52M | $38M | $50M | $55M | $38M | $37M | $37M | $31M | $29M | $31M | · | $39M | $39M | $36M | · | $30M | |
| Current Assets | $1.34B | $1.28B | $1.22B | $1.14B | $1.07B | $1000M | $951M | $892M | $944M | $935M | · | $868M | $828M | $786M | · | $724M | |
| PP&E (Net) | $147M | $134M | $117M | $98M | $85M | $72M | $63M | $60M | $58M | $76M | · | $66M | $66M | $65M | · | $64M | |
| PP&E (Gross) | · | · | $194M | · | · | · | $137M | $132M | $143M | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $77M | · | · | · | $74M | $72M | $85M | · | · | · | · | · | · | · | |
| Goodwill | $167M | $167M | $167M | $167M | $167M | $166M | $166M | $166M | $166M | $166M | · | $166M | $166M | $166M | · | $165M | |
| Intangibles | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $7M | $68M | · | $73M | $76M | $79M | · | $83M | |
| Other Non-current Assets | $41M | $41M | $41M | $40M | $40M | $44M | $41M | $39M | $39M | $34M | · | $15M | $10M | $11M | · | $13M | |
| Total Assets | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Accounts Payable | $45M | $44M | $35M | $30M | $28M | $31M | $31M | $33M | $33M | $32M | · | $28M | $26M | $28M | · | $25M | |
| Accrued Liabilities | $172M | $152M | $132M | $124M | $114M | $113M | $112M | $106M | $104M | $107M | · | $104M | $106M | $106M | · | $102M | |
| Current Liabilities | $234M | $212M | $183M | $170M | $158M | $159M | $158M | $153M | $151M | $153M | · | $145M | $144M | $146M | · | $138M | |
| Capital Leases | $176M | $179M | $183M | $180M | $183M | $185M | $187M | $190M | $192M | $195M | · | $192M | $195M | $197M | · | $181M | |
| Other Non-current Liabilities | $14M | $13M | $12M | $15M | $18M | $16M | $15M | $9M | $8M | $6M | · | $3M | $3M | $3M | · | $3M | |
| Total Liabilities | $444M | $425M | $399M | $386M | $381M | $380M | $382M | $375M | $373M | $376M | · | $364M | $366M | $371M | · | $348M | |
| Common Stock | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $39.0K | $38.0K | $38.0K | $39.0K | $39.0K | · | $38.0K | $38.0K | $38.0K | · | $38.0K | |
| Paid-in Capital | $1.22B | $1.20B | $1.19B | $1.17B | $1.15B | $1.12B | $1.10B | $1.08B | $1.08B | $1.06B | · | $1.03B | $1.00B | $979M | · | $947M | |
| Retained Earnings | $305M | $270M | $238M | $190M | $144M | $99M | $60M | $26M | $86M | $146M | · | $81M | $71M | $52M | · | $40M | |
| AOCI | $1M | $2M | $4M | $3M | $3M | $-3M | $-6M | $-963.0K | $-5M | $-5M | · | $-7M | $-6M | $-7M | · | $-13M | |
| Stockholders' Equity | $1.53B | $1.47B | $1.43B | $1.36B | $1.29B | $1.21B | $1.15B | $1.10B | $1.16B | $1.20B | $1.18B | $1.10B | $1.07B | $1.02B | $999M | $974M | |
| Liabilities + Equity | $1.97B | $1.90B | $1.83B | $1.74B | $1.67B | $1.59B | $1.53B | $1.48B | $1.53B | $1.58B | · | $1.47B | $1.43B | $1.40B | · | $1.32B | |
| Shares Outstanding | · | · | 39,229,670 | · | · | · | 38,490,836 | · | · | · | · | · | · | · | · | · |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6M | $5M | $4M | $2M | $6M | $5M | $4M | $4M | $8M | $8M | $7M | $7M | $7M | $7M | $6M | $6M | |
| Stock-based Comp | $14M | $15M | $15M | $16M | $14M | $14M | $12M | $11M | $10M | $14M | $11M | $14M | $13M | $13M | $10M | $10M | |
| Amort. of Intangibles | $181.0K | $182.0K | $182.0K | $182.0K | $178.0K | $170.0K | $170.0K | $176.0K | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Restructuring | · | · | · | · | · | · | · | $5M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $35M | · | · | · | $-9M | · | · | · | $6M | · | · | · | $-15M | · | · | |
| Operating Cash Flow | $46M | $87M | $86M | $58M | $45M | $49M | $51M | $56M | $23M | $38M | $36M | $31M | $17M | $13M | $1M | $-13M | |
| CapEx | $14M | $14M | $18M | $16M | $16M | $13M | $5M | $5M | $5M | $6M | $4M | $3M | $4M | $4M | $4M | $6M | |
| Investing Cash Flow | $-91M | $-31M | $-226M | $-163M | $-16M | $-502.0K | $-11M | $36M | $34M | $18M | $24M | $-44M | $-7M | $11M | $9M | $10M | |
| Stock Repurchased | · | · | $0 | · | · | · | $-1.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $9M | $-2M | $5M | $4M | $15M | $3M | $6M | $-101M | $8M | $-794.0K | $6M | $212.0K | $9M | $1M | $6M | $-603.0K | |
| Net Change in Cash | $-36M | $54M | $-134M | $-101M | $46M | $52M | $44M | $-8M | $65M | $56M | $67M | $-13M | $19M | $25M | $15M | $-3M | |
| Free Cash Flow | · | $73M | · | · | · | $36M | · | · | · | $32M | · | · | · | $9M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $32M | · | · | · | · | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.9% | 67.6% | · | 67.8% | 66.0% | 66.6% | · | 66.5% | 54.4% | 65.0% | · | 65.6% | 63.8% | 62.6% | · | 63.3% | |
| Operating Margin | 10.5% | 10.2% | · | 13.8% | 12.0% | 12.4% | · | 11.8% | -27.0% | 4.3% | · | 4.7% | 6.8% | 3.3% | · | 2.5% | |
| Net Margin | 8.9% | 8.7% | · | 12.9% | 13.3% | 12.1% | · | 9.8% | -20.1% | 4.0% | · | 3.4% | 7.2% | 3.5% | · | -1.1% | |
| Pretax Margin | 11.8% | 11.1% | · | 14.8% | 13.4% | 13.5% | · | 13.2% | -26.0% | 5.2% | · | 4.9% | 7.5% | 3.6% | · | 1.4% | |
| EBITDA Margin | 10.5% | 11.4% | · | 13.8% | 12.0% | 14.0% | · | 11.8% | -27.0% | 7.0% | · | 4.7% | 6.8% | 6.0% | · | 2.5% | |
| ROA | 1.9% | 1.9% | · | 2.8% | 2.8% | 2.5% | · | 2.0% | -4.1% | 0.74% | · | 0.66% | 1.4% | 0.63% | · | -0.20% | |
| ROE | 2.5% | 2.4% | · | 3.7% | 3.7% | 3.2% | · | 2.7% | -5.4% | 0.99% | · | 0.89% | 1.9% | 0.86% | · | -0.27% | |
| ROIC | 2.0% | 2.0% | · | 3.1% | 3.2% | 3.0% | · | 2.4% | -5.4% | 0.76% | · | 0.79% | 1.6% | 0.77% | · | -0.42% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.7 | 6.0 | · | 6.7 | 6.8 | 6.3 | · | 5.8 | 6.3 | 6.1 | · | 6.0 | 5.7 | 5.4 | · | 5.2 | |
| Quick Ratio | 1.7 | 2.0 | · | 3.0 | 3.8 | 3.4 | · | 3.0 | 3.2 | 2.7 | · | 2.1 | 2.2 | 2.1 | · | 1.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -235.4 | 30.1 | · | · | · | · | · | · |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 2.1 | 2.1 | · | 2.0 | 1.8 | 1.8 | · | 1.6 | 1.5 | 1.4 | · | 1.4 | 1.3 | 1.4 | · | 1.4 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $9.86 | $9.48 | · | $9.02 | $8.65 | $8.28 | · | $7.68 | $7.72 | $7.07 | · | $6.91 | $6.67 | $6.18 | · | $5.64 | |
| Cash Flow / Share | · | $2.20 | · | · | · | $1.25 | · | · | · | $0.97 | · | · | · | $0.34 | · | · | |
| EPS (TTM) | $4.07 | $4.34 | · | $4.20 | $3.78 | $1.08 | · | $0.87 | $0.35 | $2.38 | · | $1.04 | $0.75 | $0.17 | · | $-0.83 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.50B | $1.45B | · | $1.33B | $1.28B | $1.24B | · | $1.16B | $1.13B | $1.10B | · | $995M | $938M | $885M | · | $830M | |
| Net Income TTM | $161M | $171M | · | $164M | $148M | $42M | · | $35M | $14M | $93M | · | $41M | $29M | $6M | · | $-31M | |
| P/E | 77.6 | 75.7 | · | 60.3 | 67.9 | 247.6 | · | 223.3 | 514.2 | 93.8 | · | 232.6 | 458.7 | 1639.4 | · | -228.4 | |
| Earnings Yield | 1.3% | 1.3% | · | 1.7% | 1.5% | 0.40% | · | 0.45% | 0.19% | 1.1% | · | 0.43% | 0.22% | 0.06% | · | -0.44% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $1.40B | $1.19B | $1.06B | $847M | $748M |
| Brüt Kâr Marjı % | 67.1% | 63.2% | 64.5% | 63.2% | 63.6% |
| Faaliyet Kâr Marjı % | 13.5% | 0.78% | 7.0% | 0.72% | -1.0% |
| Net Gelir | $178M | $14M | $91M | $-2M | $5M |
| Seyreltilmiş Hisse Başı Kâr | $4.52 | $0.36 | $2.32 | $-0.05 | $0.14 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 6.6 | 6.0 | 6.1 | 5.2 | 5.5 |
| Cari Oran | 2.1 | 3.1 | 2.4 | 1.9 | 1.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $175M | $147M | $82M | $-75M | $-12M |
Kurumsal Sahipler (13F) 490 dosya · $12.1B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
490
Tutulan Değer
$12.1B
Yeni pozisyonlar
46
Çıkan pozisyonlar
67
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 46 (-96 önceki Ç'ye göre) | 67 (-9 önceki Ç'ye göre) | 148 (-1 önceki Ç'ye göre) | 186 (+50 önceki Ç'ye göre) | +877K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $1.356.952.992 | 4.297.555 | 11,19% | Hisse senetleri |
| VANGUARD GROUP INC | $1.172.307.607 | 3.770.569 | 9,67% | Hisse senetleri |
| HBK INVESTMENTS L P | $580.508.901 | 1.838.508 | 4,79% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $539.893.663 | 1.709.877 | 4,45% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $526.442.397 | 1.667.276 | 4,34% | Hisse senetleri |
| STATE STREET CORP | $392.556.505 | 1.243.258 | 3,24% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $344.303.272 | 1.090.430 | 2,84% | Hisse senetleri |
| Balyasny Asset Management L.P. | $344.218.967 | 1.090.163 | 2,84% | Hisse senetleri |
| JPMORGAN CHASE & CO | $338.557.982 | 1.071.454 | 2,79% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $267.473.088 | 847.104 | 2,21% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $263.620.622 | 834.903 | 2,17% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $251.546.090 | 796.471 | 2,07% | Hisse senetleri |
| NORGES BANK | $237.520.412 | 752.242 | 1,96% | Hisse senetleri |
| UBS Group AG | $222.231.798 | 703.822 | 1,83% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $221.217.923 | 700.611 | 1,82% | Hisse senetleri |
| MORGAN STANLEY | $186.869.151 | 591.824 | 1,54% | Hisse senetleri |
| AQR Arbitrage LLC | $178.042.900 | 563.873 | 1,47% | Hisse senetleri |
| WHITEBOX ADVISORS LLC | $160.047.676 | 506.881 | 1,32% | Hisse senetleri |
| Capital World Investors | $151.465.591 | 479.701 | 1,25% | Hisse senetleri |
| CITADEL ADVISORS LLC | $141.696.917 | 448.763 | 1,17% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $138.473.110 | 438.553 | 1,14% | Hisse senetleri |
| CITIGROUP INC | $136.759.219 | 433.125 | 1,13% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $135.181.416 | 428.128 | 1,11% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $126.504.922 | 400.649 | 1,04% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $108.527.380 | 343.713 | 0,89% | Hisse senetleri |
| NORTHERN TRUST CORP | $105.164.958 | 333.064 | 0,87% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $102.972.179 | 326.120 | 0,85% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $99.031.466 | 301.585 | 0,82% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $83.994.867 | 266.017 | 0,69% | Hisse senetleri |
| Invesco Ltd. | $83.351.684 | 263.980 | 0,69% | Hisse senetleri |
| Magnetar Financial LLC | $80.781.796 | 255.841 | 0,67% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $79.488.800 | 251.746 | 0,66% | Hisse senetleri |
| Bank of New York Mellon Corp | $74.304.811 | 235.328 | 0,61% | Hisse senetleri |
| Champlain Investment Partners, LLC | $69.159.354 | 219.032 | 0,57% | Hisse senetleri |
| TIG Advisors, LLC | $67.912.141 | 215.082 | 0,56% | Hisse senetleri |
| LMR Partners LLP | $67.536.715 | 213.893 | 0,56% | Hisse senetleri |
| FMR LLC | $66.623.786 | 211.002 | 0,55% | Hisse senetleri |
| Hudson Bay Capital Management LP | $64.140.823 | 203.138 | 0,53% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $63.150.000 | 200.000 | 0,52% | Satım opsiyonu |
| D. E. Shaw & Co., Inc. | $62.306.632 | 197.329 | 0,51% | Hisse senetleri |
| ALPINE ASSOCIATES MANAGEMENT INC. | $59.672.330 | 188.986 | 0,49% | Hisse senetleri |
| Melqart Asset Management (UK) Ltd | $58.645.511 | 185.734 | 0,48% | Hisse senetleri |
| CAXTON ASSOCIATES LLP | $56.640.498 | 179.384 | 0,47% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $55.799.340 | 176.720 | 0,46% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $55.540.425 | 175.900 | 0,46% | Satım opsiyonu |
| JANUS HENDERSON GROUP PLC | $54.849.328 | 167.054 | 0,45% | Hisse senetleri |
| Birnam Oak Advisors, LP | $54.080.713 | 171.277 | 0,45% | Hisse senetleri |
| Westchester Capital Management, LLC | $49.721.784 | 157.472 | 0,41% | Hisse senetleri |
| WATER ISLAND CAPITAL LLC | $47.506.483 | 150.456 | 0,39% | Hisse senetleri |
| Woodline Partners LP | $46.050.243 | 145.844 | 0,38% | Hisse senetleri |
Şirket yöneticileri 19 içeriden öğrenenler · 5 yöneticiler · 7 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Adam Elsesser | CEO | 19 Mayıs 2026 G | 683.042 | 0 | 0 | $0 |
| Maggie Yuen | Chief Financial Officer | 15 Mart 2026 F | 18.167 | 0 | 1 | $-832.474 |
| Shruthi Narayan | President | 15 Eylül 2026 F | 32.650 | 0 | 0 | $0 |
| Lambert Shiu | Chief Accounting Officer | 15 Mart 2026 F | 39.323 | 0 | 0 | $0 |
| Johanna Roberts | EVP, Gen. Counsel & Secretary | 15 Mart 2026 F | 67.298 | 0 | 16 | $-967.303 |
| Surbhi Sarna | Yönetim kurulu üyesi | 13 Şubat 2026 A | 4.293 | 0 | 0 | $0 |
| Janet Leeds | Yönetim kurulu üyesi | 13 Şubat 2026 A | 6.639 | 0 | 0 | $0 |
| Bridget O'Rourke | Yönetim kurulu üyesi | 13 Şubat 2026 A | 5.962 | 0 | 0 | $0 |
| Arani Bose | Yönetim kurulu üyesi | 13 Şubat 2026 A | 1.147 | 0 | 10 | $-9.062.931 |
| Thomas Wilder | Yönetim kurulu üyesi | 13 Şubat 2026 A | 589 | 0 | 1 | $-57.794 |
| Walter Charles Wang | Yönetim kurulu üyesi | 04 Mart 2016 A | 521.071 | 0 | 0 | $0 |
| Harpreet Grewal | · | 02 Nisan 2026 S | 8.719 | 0 | 4 | $-162.601 |
| Don W. Kassing | · | 14 Şubat 2025 A | 1.409 | 0 | 0 | $0 |
| James Robert Pray | · | 01 Ekim 2021 S | 408.431 | 0 | 0 | $0 |
| Lynn Rothman | · | 01 Ekim 2021 M | 32.637 | 0 | 0 | $0 |
| Sridhar Kosaraju | · | 15 Nisan 2020 S | 155.351 | 0 | 0 | $0 |
| Daniel Donen Davis | · | 27 Aralık 2018 M | 64.277 | 0 | 0 | $0 |
| Robert D. Evans | · | 30 Ağustos 2018 M | 15.667 | 0 | 0 | $0 |
| Kevin James Sullivan | · | 31 Ağustos 2016 S | 29.449 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 67 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| RSBA · Tidal Trust II | 4,65% | 7.617 NS | 31 Temmuz 2026 | N-PORT |
| NEWZ · EA Series Trust | 3,43% | 2.085 NS | 31 Temmuz 2026 | N-PORT |
| MNA · New York Life Investments ETF Trust | 2,11% | 16.553 NS | 31 Temmuz 2026 | N-PORT |
| IHI · iShares Trust | 1,88% | 188.033 SH | 11 Eylül 2026 | Günlük |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,65% | 3.558 NS | 31 Temmuz 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,95% | 9.963 SH | 02 Ekim 2026 | Günlük |
| MEDI · Harbor ETF Trust | 0,77% | 987 NS | 31 Temmuz 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,65% | 38.809 SH | 19 Ağustos 2026 | Günlük |
| IQSM · New York Life Investments ETF Trust | 0,46% | 4.773 NS | 31 Temmuz 2026 | N-PORT |
| PAMC · Pacer Funds Trust | 0,43% | 712 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,40% | 12.024 SH | 11 Eylül 2026 | Günlük |
| NUSC · Nushares ETF Trust | 0,39% | 15.774 NS | 31 Temmuz 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,36% | 4.350 NS | 31 Temmuz 2026 | N-PORT |
| IWP · iShares Trust | 0,36% | 214.670 SH | 11 Eylül 2026 | Günlük |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,34% | 63.544 SH | 19 Ağustos 2026 | Günlük |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 495.123 SH | 19 Ağustos 2026 | Günlük |
| BKMC · BNY Mellon ETF Trust | 0,31% | 6.335 NS | 31 Temmuz 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 4.348 NS | 31 Temmuz 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,29% | 1.182 NS | 31 Temmuz 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0,27% | 578 NS | 31 Temmuz 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,26% | 16.632 NS | 31 Temmuz 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 18.226 NS | 31 Temmuz 2026 | N-PORT |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 50.475 NS | 31 Temmuz 2026 | N-PORT |
| IYH · iShares Trust | 0,19% | 22.263 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 17.746 NS | 31 Temmuz 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,17% | 13.412 NS | 31 Temmuz 2026 | N-PORT |
| ESML · iShares Trust | 0,17% | 15.152 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,17% | 112.334 SH | 19 Ağustos 2026 | Günlük |
| SMMD · iShares Trust | 0,17% | 20.300 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,15% | 12.370 SH | 02 Ekim 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,14% | 451.358 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,14% | 856.800 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,12% | 59.193 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,11% | 2.287 SH | 11 Eylül 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 2.375 SH | 02 Ekim 2026 | Günlük |
| IWR · iShares Trust | 0,09% | 156.309 SH | 11 Eylül 2026 | Günlük |
| RILA · Spinnaker ETF Series | 0,07% | 88 NS | 31 Temmuz 2026 | N-PORT |
| XT · iShares Trust | 0,07% | 8.117 SH | 11 Eylül 2026 | Günlük |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 2.477 SH | 02 Ekim 2026 | Günlük |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 60.327 SH | 19 Ağustos 2026 | Günlük |
| IWF · iShares Trust | 0,04% | 143.096 SH | 11 Eylül 2026 | Günlük |
| IUSG · iShares Trust | 0,03% | 35.012 SH | 11 Eylül 2026 | Günlük |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,03% | 3.819 SH | 02 Ekim 2026 | Günlük |
| TILT · FlexShares Trust | 0,02% | 1.422 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,02% | 1.186.275 SH | 19 Ağustos 2026 | Günlük |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 6.349 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,02% | 3.208 SH | 19 Ağustos 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,02% | 8.611 SH | 19 Ağustos 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,02% | 27.709 NS | 31 Temmuz 2026 | N-PORT |
| IYY · iShares Trust | 0,02% | 1.685 SH | 10 Eylül 2026 | Günlük |
| IWB · iShares Trust | 0,02% | 26.117 SH | 11 Eylül 2026 | Günlük |
| ITOT · iShares Trust | 0,02% | 50.889 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,02% | 10.594 SH | 10 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,02% | 6.022 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,02% | 9.928 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 1.400 NS | 31 Temmuz 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 810 NS | 31 Temmuz 2026 | N-PORT |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 30.658 SH | 19 Ağustos 2026 | Günlük |
| EPU · iShares Trust | 0,00% | 19.935 SH | 11 Eylül 2026 | Günlük |
| DYNF · BlackRock ETF Trust | 0,00% | 42 SH | 24 Ağustos 2026 | Günlük |
| EEMS · iShares, Inc. | 0,00% | 100 SH | 26 Ağustos 2026 | Günlük |
| IJH · iShares Trust | · | 1.380.497 SH | 11 Eylül 2026 | Günlük |
| IJK · iShares Trust | · | 228.092 SH | 11 Eylül 2026 | Günlük |
| XJH · iShares Trust | · | 5.373 SH | 08 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 1.708 SH | 11 Eylül 2026 | Günlük |
| SMLF · iShares Trust | · | 10.495 SH | 11 Eylül 2026 | Günlük |
| SMMV · iShares Trust | · | 5.954 SH | 01 Eylül 2026 | Günlük |
PEN Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 20 analist
TUT
Medyan hedef
$374.00
+17,8%
1 5,0%
Güçlü Al
5 25,0%
Al
14 70,0%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
12 analist · 2026-10-02Ortalama hedef $361.83 +13,9%
← Tüm hedeflerin altında
Mevcut fiyat $317.55
Düşük$323.00
Ortalama$361.83
Yüksek$374.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 30, 2026